To establish whether LHX2 activates the PI3K/AKT/mTOR pathway and apoptosis pathway in breast cancer, we conducted a Western blotting assay to detect the signature proteins in these pathways, including PI3K, p-PI3K, Akt, p-Akt, Bcl-2, and Bax. Here, BCL2 is linked to breast carcinoma.